# Novo Nordisk A/S (NYSE: NVO), Kalundborg, Denmark – FDA Inspections

Source: https://www.keypedia.com/companies/novo-nordisk-as/b48359f1-0bb7-4fff-80dd-688aab40951b

> Inspection records and compliance data for Novo Nordisk A/S in Kalundborg. 11 FDA inspections on record, 2 Form 483s, last inspected March 25, 2024. Publicly traded as NYSE: NVO.

---

## Details

- Name: Novo Nordisk A/S
- FEI Number: 3002807751
- Address Line 1: Hallas Alle 1
- City: Kalundborg
- Country Name: Denmark
- Address: Hallas Alle 1, Kalundborg, Denmark
- Country: Denmark

## Stock

- Stock ticker: NVO
- Exchange: NYSE
- Share price: $40.66
- Market cap: $180.0B
- Price as of: November 13, 2026

## Related Documents

- [483 - Novo Nordisk A/S - 2024-03-25](https://www.keypedia.com/records/483/novo-nordisk-as/a1d0c5be-baef-49e2-8029-c33585c3f80a) — source: FDA, date: March 25, 2024
- MEMO - Novo Nordisk A/S - 2024-03-25 — source: FDA, date: March 25, 2024
- [EIR - Novo Nordisk A/S - 2024-03-25](https://www.keypedia.com/records/eir/novo-nordisk-as/e5940682-7d77-485a-a366-11b1f33ca5dc) — source: FDA, date: March 25, 2024
- [FDA Inspection 1269488 - Novo Nordisk A/S - 2024-03-25](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/06fe2bd0-d7e0-4521-9fdf-92aaf736552d) — source: FDA, date: March 25, 2024
- [483 - Novo Nordisk A/S - 2023-05-04](https://www.keypedia.com/records/483/novo-nordisk-as/c88acfb5-d361-4369-8bff-87d2b9102820) — source: FDA, date: May 4, 2023
- [FDA Inspection 1209127 - Novo Nordisk A/S - 2023-05-04](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/66074870-de76-43e2-b8fd-c93d30311f61) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2023
- FDA Inspection 1230597 - Novo Nordisk A/S - 2022-12-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 2, 2022
- FDA Inspection 1107225 - Novo Nordisk A/S - 2019-09-06 — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2019
- FDA Inspection 1044502 - Novo Nordisk A/S - 2018-03-07 — source: FDA, date: March 7, 2018
- FDA Inspection 1028554 - Novo Nordisk A/S - 2017-08-29 — classification: No Action Indicated (NAI), source: FDA, date: August 29, 2017
- FDA Inspection 872670 - Novo Nordisk A/S - 2014-03-07 — classification: No Action Indicated (NAI), source: FDA, date: March 7, 2014
- FDA Inspection 861829 - Novo Nordisk A/S - 2013-05-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2013
- FDA Inspection 777396 - Novo Nordisk A/S - 2012-03-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2012
- FDA Inspection 730949 - Novo Nordisk A/S - 2011-02-08 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 8, 2011

## Related Companies

- [OHM Pharma, Inc.](https://www.keypedia.com/companies/ohm-pharma-inc/c3ecfcf1-4d7d-4404-be13-ea1bdc864d14)
- [Chemisphere Corporation](https://www.keypedia.com/companies/chemisphere-corporation/60ff2ab3-c198-4dea-ab82-539d7bf5fbc0)
- [Altaire Pharmaceuticals, Inc.](https://www.keypedia.com/companies/altaire-pharmaceuticals-inc/1e892910-1e24-4697-87c3-61cc48735f49)
- [Church & Dwight Co., Inc.](https://www.keypedia.com/companies/church-dwight-co-inc/d87194ae-f106-4ad7-9bc2-49ca798f781d)
- [Eastman Chemical Company](https://www.keypedia.com/companies/eastman-chemical-company/bd851c43-4385-4381-8bad-133ea397caf7)
- [King Bio Inc.](https://www.keypedia.com/companies/king-bio-inc/bad7278d-85cb-43ee-99a5-4cb9b13a45ea)
- [Sage Products, LLC](https://www.keypedia.com/companies/sage-products-llc/0f9d73bb-cc3e-4880-bea8-3496d8fd6397)
- [Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.](https://www.keypedia.com/companies/zhejiang-jinhua-conba-bio-pharm-co-ltd/ccf6fb2b-5de1-4f70-903b-d442374003f6)
- [Best Sanitizers Inc](https://www.keypedia.com/companies/best-sanitizers-inc/909061b5-e25d-44be-a943-42f8624f27d7)
- [Alto ICP, LLC](https://www.keypedia.com/companies/alto-icp-llc/bc6bac2f-8575-40c1-a90c-25f152eb71fd)

## Related Officers

- [Sergey S. Akimov](https://www.keypedia.com/people/sergey-s-akimov/4eca8d78-ef17-49a7-aaa1-5fa8fecf0383)
- [Mikhail Ovanesov](https://www.keypedia.com/people/mikhail-ovanesov/5167a693-fb5c-485d-b8e9-50ce8a6bdd90)
- [Zachary Kraus](https://www.keypedia.com/people/zachary-kraus/9a85297e-4a21-49a6-a848-bc4a1e759f1a)
- [Maxwell Koranyi-Ofori](https://www.keypedia.com/people/maxwell-koranyi-ofori/ddd48c5d-a543-4061-abb1-827deda5d72d)
- [company_representative](https://www.keypedia.com/people/stefan-nielsen/26d381e5-bcc0-436b-8ddd-8abfbf61ed5d)
- [recipient](https://www.keypedia.com/people/mai-britt-hammer-frost-thomasen/32d1d2a1-b2e0-4804-9493-0ae74df4751d)
